Jefferies Top Drug Stocks for the Rest of 2016
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Looking outside the United States can sometimes reveal other companies that offer the same stability, with the added benefit of global diversification if a U.S.-specific problem develops.
24/7 Wall St. screened the Merrill Lynch research universe for large-cap blue chip stocks that paid a 5% dividend.
Tuesday's top analyst upgrades, downgrades and initiations include Bluebird Bio, Boston Beer, Etsy, Gilead Sciences, Pfizer, PMC-Sierra and Valeant Pharmaceuticals.
Friday's top analyst upgrades, downgrades and initiations include Charles Schwab, 3D Systems, Stratasys, Groupon, Lifepoint Health and E*Trade.
ThinkstockAny time that you hear about new drugs and medical treatments, they tend to be around ongoing treatments rather than cures. And when it comes to AIDS and HIV, the past has…
Tuesday's top analyst upgrades and downgrades from 24/7 Wall St. include Cisco Systems, Dreamworks Animation, Lululemon Athletica, Schlumberger and Verizon Communications.
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some radical changes on the surface, some of…
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. for Monday, September 22, 2014.
courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) released its public equity holdings as of June 30, 2014. Warren Buffett’s different portfolio holdings have not been changing much of late, but it turns…
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Monday, July 28, 2014. They include AcelRx Pharmaceuticals, Cisco Systems, Juniper Networks, Pfizer and Xerox.
The Department of Defense awarded $409 million in defense contracts Friday. Hewlett Packard won the day's largest award. The company will continue to providing information technology services at nearly 2,500 Navy and…
Amgen submitted an SEC Filing showing that, as of April 1, one of its subsidiaries and a GlaxoSmithKline subsidiary have terminated part and amended part of a collaboration agreement from 2009.
White House Photo by Pete SouzaAs many consider Warren Buffett to be the greatest investor of modern times, investors want to know any time there are big changes in the Berkshire Hathaway…